TME PHARMA ANNONCE LA PRSENTATION DUN POSTER PAR LE NATIONAL CANCER INSTITUTE AMRICAIN SUR LINHIBITION DE CXCL12 PAR NOX-A12 DANS LE GLIOBLASTOME A LA REUNION ANNUELLE DU SNO 2024
| HCMAX Etf | USD 28.61 0.14 0.49% |
Slightly above 62% of THE HILLMAN's investor base is looking to short. The analysis of overall sentiment of trading THE HILLMAN FUND etf suggests that many investors are alarmed at this time. THE HILLMAN's investing sentiment can be driven by a variety of factors including economic data, THE HILLMAN's earnings reports, geopolitical events, and overall market trends.
THE |
TME Pharma N.V. , une socit de biotechnologie au stade clinique spcialise dans le dveloppement de nouvelles thrap
Read at businesswire.com
 |
THE HILLMAN Fundamental Analysis
We analyze THE HILLMAN's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THE HILLMAN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THE HILLMAN based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
THE HILLMAN is rated # 5 ETF in three year return as compared to similar ETFs. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
THE HILLMAN FUND Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with THE HILLMAN etf to make a market-neutral strategy. Peer analysis of THE HILLMAN could also be used in its relative valuation, which is a method of valuing THE HILLMAN by comparing valuation metrics with similar companies.
Peers
THE HILLMAN Related Equities
| MBBB | VanEck Vectors | 0.14 | ||||
| MBNE | SSGA Active | 0.00 | ||||
| MBOX | Freedom Day | 0.26 | ||||
| HCMAX | THE HILLMAN | 0.49 | ||||
| DHDG | FT Vest | 0.81 | ||||
| Z | Zillow Group | 1.32 | ||||
| MBCC | Northern Lights | 1.47 |
Other Information on Investing in THE Etf
THE HILLMAN financial ratios help investors to determine whether THE Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in THE with respect to the benefits of owning THE HILLMAN security.